Which of the following is NOT a characteristic of Meglitinides?

Meglitinides are a class of oral hypoglycemic agents primarily used to manage blood glucose levels in individuals with type 2 diabetes. Their mechanism of action involves stimulating the pancreas to release insulin, which is particularly effective after meals when blood sugar levels are likely to rise.

These medications are designed to be taken just before meals to optimize their effect on postprandial (after meal) blood glucose levels. This approach helps in reducing the risk of high blood sugar spikes that occur after eating.

While Meglitinides can lead to some adverse effects, including the potential for hypoglycemia—especially if meals are missed or delayed—the primary aim of these medications is to manage blood sugar rather than induce weight loss. In fact, weight loss is not commonly associated with Meglitinides; instead, users may experience neutral or, in some cases, weight gain, depending on their overall treatment plan and lifestyle.

Thus, the statement that Meglitinides cause weight loss is not accurate for this class of medications, making it the correct answer to identify as NOT a characteristic of Meglitinides.